Study of GV20-0251 in Participants With Solid Tumor Malignancies

Clinical trial NCT07070518 · RECRUITING

Trial details

NCT number: NCT07070518
Sponsor: GV20 Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Cancer Adult Refractory Cancer Endometrial Carcinoma (EC)Squamous Head and Neck Carcinoma pMMR/MSS Adenocarcinoma of the Colon or Rectum Non-Small Cell Lung Cancer Melanoma HCC - Hepatocellular Carcinoma Small Cell Lung Cancer

Start date: 2025-07-11
Primary completion: 2027-07-16
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.